NEW YORK, Jan. 28, 2011 (GLOBE NEWSWIRE) -- Attorney Advertising. The law firm of Harwood Feffer LLP is investigating potential violations of the federal securities laws by MannKind Corporation ("MannKind" or the "Company") (Nasdaq:MNKD). The investigation focuses on whether a series of statements regarding MannKind's disclosures related to the clinical utility and Food and Drug Administration approval of AFREZZA were materially false and misleading.
Harwood Feffer has been representing individual and institutional investors for many years, serving as lead counsel in numerous cases in federal and state courts. Please visit the Harwood Feffer LLP website () for more information about the firm.
If you purchased MannKind common stock between June 25, 2010 and January 19, 2011 and suffered a loss in excess of $100,000 and you wish to discuss this matter with us, or have any questions concerning your rights and interests with regard to this matter, please contact:
Robert I. Harwood, Esq.
Samuel K. Rosen, Esq.
Harwood Feffer LLP
488 Madison Avenue
New York, New York 10022
Phone Numbers: (877) 935-7400
(212) 935-7400
Email: rharwood@hfesq.com
srosen@jfesq.com
Website:
The Harwood Feffer LLP logo is available at
Attorney Advertising: Prior Results Do Not Guarantee A Similar Outcome.
CONTACT: Harwood Feffer LLP Robert I. Harwood, (877) 935-7400 or (212) 935-7400 rharwood@hfesq.com Samuel K. Rosen, (877) 935-7400 or (212) 935-7400 srosen@hfesq.com
